Ezgi Turunc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ezgi Turunc has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Guliz Armagan
Department of Biochemistry, Faculty of Pharmacy, Ege University, Bornova 35100, Turkey
12 shared publications - Ayfer Yalcin
Ege University, Faculty of Pharmacy, Department of Biochemistry
8 shared publications Lutfiye Kanit
Department of Neurosciences, Health Science Institute, Ege University, Bornova, Izmir 35100, Turkey; Department of Physiology, Faculty of Medicine, Ege University, Bornova, Izmir 35100, Turkey
8 shared publicationsAyfer Yalcin
Department of Biochemistry, Faculty of Pharmacy, Ege University, Bornova, Izmir 35100, Turkey; Department of Neurosciences, Health Science Institute, Ege University, Bornova, Izmir 35100, Turkey
5 shared publicationsAnna Borsodi
4 shared publications- Sándor Benyhe
HUN-REN Biological Research Center,Szeged,Hungary, Hungary
4 shared publications
Latest Publications
- 5 August 2024
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 15 (17) , 8689-8699
Cinnamon extracts, trans-cinnamaldehyde and trans-cinnamic acid inhibit HDAC 1 activity
Essential oil and 70% ethanol extract of Cinnamomum cassia bark can be evaluated to be used in products against HDAC 1 related diseases.
- 5 August 2024
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 15 (17) , 8689-8699
Cinnamon extracts, trans-cinnamaldehyde and trans-cinnamic acid inhibit HDAC 1 activity
Essential oil and 70% ethanol extract of Cinnamomum cassia bark can be evaluated to be used in products against HDAC 1 related diseases.
- 9 January 2024
- Published by Hacettepe University in Hacettepe University Journal of the Faculty of Pharmacy
INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON'S DISEASE IN RATS EXPOSED TO PRENATAL STRESS
INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON’S DISEASE IN RATS EXPOSED TO PRENATAL STRESS Ilayda VAROL1*, Sinem Ezgi TURUNC OZOGLU2 1 Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye 2 Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye ORCID Numbers: İlayda Varol: 0009-0000-4037-8612 Sinem Ezgi Turunc Ozoglu: 0000-0002-7587-7443 *Corresponding author: Ilayda VAROL Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye E-mail: varolilayda@gmail.com Tel: +90 507 333 18 35 Ethical Committee Approval: The Ege University Ethics Committee on Animal Experiments approved this study (05/24/2017; Reference No. 2017-023). INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON’S DISEASE IN RATS EXPOSED TO PRENATAL STRESS Abstract This study was carried out in order to better understand how prenatal stress (PS) may affect the future onset of Parkinson's disease (PD). A dexamethasone-induced PS model was established in rats for the study. Changes in the expression levels of tyrosine hydroxylase (TH), α-synuclein (SNCA), dopamine transporter (SLC6A3), and parkin (PRKN) proteins, which play role in PD pathogenesis, were demonstrated by real-time PCR in the cerebral cortex of male rats exposed to PS. From GD 14 to 21, pregnant rats were injected daily with Dex or saline (100 μg/kg and 1 ml/kg). 3 months after birth, male rats underwent decapitation (n=5), cerebral cortex dissection was performed. Total RNA was isolated from cortexes and used for cDNA synthesis. Gene expression analyzes were performed according to the ∆∆CT method. The statistical differences between groups were analyzed by the Mann-Whitney test. Statistics were deemed significant at a level of 0.05. Dex exposure throughout pregnancy significantly increased mRNA levels of TH and SLC6A3. No significant differences were found in the mRNA levels of PRKN and SNCA between experimental groups. In conclusion, offspring exposed to PS may be more susceptible to PD in adulthood through changes in the cortical mRNA levels of TH and SLC6A3. Keywords: Prenatal stress, Parkinson’s Disease, Tyrosine hydroxylase, Dopamine transporter
- 9 January 2024
- Published by Hacettepe University in Hacettepe University Journal of the Faculty of Pharmacy
INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON'S DISEASE IN RATS EXPOSED TO PRENATAL STRESS
INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON’S DISEASE IN RATS EXPOSED TO PRENATAL STRESS Ilayda VAROL1*, Sinem Ezgi TURUNC OZOGLU2 1 Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye 2 Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye ORCID Numbers: İlayda Varol: 0009-0000-4037-8612 Sinem Ezgi Turunc Ozoglu: 0000-0002-7587-7443 *Corresponding author: Ilayda VAROL Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Çelebi University, Izmir, Türkiye E-mail: varolilayda@gmail.com Tel: +90 507 333 18 35 Ethical Committee Approval: The Ege University Ethics Committee on Animal Experiments approved this study (05/24/2017; Reference No. 2017-023). INVESTIGATION OF GENE EXPRESSION LEVELS OF SOME PROTEINS RELATED TO THE PATHOGENESIS OF PARKINSON’S DISEASE IN RATS EXPOSED TO PRENATAL STRESS Abstract This study was carried out in order to better understand how prenatal stress (PS) may affect the future onset of Parkinson's disease (PD). A dexamethasone-induced PS model was established in rats for the study. Changes in the expression levels of tyrosine hydroxylase (TH), α-synuclein (SNCA), dopamine transporter (SLC6A3), and parkin (PRKN) proteins, which play role in PD pathogenesis, were demonstrated by real-time PCR in the cerebral cortex of male rats exposed to PS. From GD 14 to 21, pregnant rats were injected daily with Dex or saline (100 μg/kg and 1 ml/kg). 3 months after birth, male rats underwent decapitation (n=5), cerebral cortex dissection was performed. Total RNA was isolated from cortexes and used for cDNA synthesis. Gene expression analyzes were performed according to the ∆∆CT method. The statistical differences between groups were analyzed by the Mann-Whitney test. Statistics were deemed significant at a level of 0.05. Dex exposure throughout pregnancy significantly increased mRNA levels of TH and SLC6A3. No significant differences were found in the mRNA levels of PRKN and SNCA between experimental groups. In conclusion, offspring exposed to PS may be more susceptible to PD in adulthood through changes in the cortical mRNA levels of TH and SLC6A3. Keywords: Prenatal stress, Parkinson’s Disease, Tyrosine hydroxylase, Dopamine transporter
- Open Access
- 25 December 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (4) , 259-266
Altered Levels of Gene Expression of Drug Metabolism Enzymes in Rat Brain Following Kainic Acid Treatment
Objectives: Previous studies have shown that gene expressions can be regulated in the hippocampus of rats after seizures induced by kainic acid (KA). The aim of this study was to examine the potential regulatory impact of KA administration on gene expression levels of enzymes responsible for drug metabolism in rat hippocampal tissue. Materials and Methods: Rats received intraperitoneal injections of KA and saline at a dose of 10 mg/kg. Behavioral changes were observed in experimental animals following the administration of KA. Four hours after receiving treatments, all rats were decapitated, and the brains were removed. Hippocampal tissues were used for total RNA isolation, and cDNA synthesis was performed by reverse transcription polymerase chain reaction (PCR). Gene expression levels of enzymes responsible for drug metabolism were determined by quantitative PCR using the RT2 2 Profiler PCR Array Rat Drug Metabolism PCR array system containing the relevant primers for a total of 84 genes. The gene expression levels of drug- metabolizing enzymes were quantified using the comparative Ct (2-Delta Delta(delta delta)Ct ) method. The Student's t-test was used for data analysis. Results: Our results indicate that KA treatment caused significant changes in the gene expression levels of metallothionein 3, glucose phosphate isomerase, adenosine triphosphate-binding cassette protein C1, cytochrome P450 enzymes (Cyp2c6v1, Cyp3a23/3a1, Cyp2c7), glutathione peroxidase 1, 4, and 5, glutamic acid decarboxylase 1 and 2, paraoxonase 2, carbohydrate sulfotransferase 1, glutathione S-transferases (Gsta3, Gstm1, Gstm4), microsomal glutathione S-transferase 3, carboxylesterase 2C, fatty acid amide hydrolase, pyruvate kinase-muscle, arachidonate 5-lipoxygenase, apolipoprotein E, cytochrome b5 reductase 5, xanthine dehydrogenase, N-acetyltransferase 1, glucokinase regulator, hexokinase 2, myristoylated alanine rich protein kinase C substrate, and stannin in the hippocampus compared with the control (p p < 0.05). Conclusion: As a conclusion, it can be said that the seizure activity triggered by KA has the potential to change the gene expression levels of the enzymes responsible for drug metabolism in the hippocampus of rats.
- 25 December 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (4) , 259-266
Open AccessAltered Levels of Gene Expression of Drug Metabolism Enzymes in Rat Brain Following Kainic Acid Treatment
Objectives: Previous studies have shown that gene expressions can be regulated in the hippocampus of rats after seizures induced by kainic acid (KA). The aim of this study was to examine the potential regulatory impact of KA administration on gene expression levels of enzymes responsible for drug metabolism in rat hippocampal tissue. Materials and Methods: Rats received intraperitoneal injections of KA and saline at a dose of 10 mg/kg. Behavioral changes were observed in experimental animals following the administration of KA. Four hours after receiving treatments, all rats were decapitated, and the brains were removed. Hippocampal tissues were used for total RNA isolation, and cDNA synthesis was performed by reverse transcription polymerase chain reaction (PCR). Gene expression levels of enzymes responsible for drug metabolism were determined by quantitative PCR using the RT2 2 Profiler PCR Array Rat Drug Metabolism PCR array system containing the relevant primers for a total of 84 genes. The gene expression levels of drug- metabolizing enzymes were quantified using the comparative Ct (2-Delta Delta(delta delta)Ct ) method. The Student's t-test was used for data analysis. Results: Our results indicate that KA treatment caused significant changes in the gene expression levels of metallothionein 3, glucose phosphate isomerase, adenosine triphosphate-binding cassette protein C1, cytochrome P450 enzymes (Cyp2c6v1, Cyp3a23/3a1, Cyp2c7), glutathione peroxidase 1, 4, and 5, glutamic acid decarboxylase 1 and 2, paraoxonase 2, carbohydrate sulfotransferase 1, glutathione S-transferases (Gsta3, Gstm1, Gstm4), microsomal glutathione S-transferase 3, carboxylesterase 2C, fatty acid amide hydrolase, pyruvate kinase-muscle, arachidonate 5-lipoxygenase, apolipoprotein E, cytochrome b5 reductase 5, xanthine dehydrogenase, N-acetyltransferase 1, glucokinase regulator, hexokinase 2, myristoylated alanine rich protein kinase C substrate, and stannin in the hippocampus compared with the control (p p < 0.05). Conclusion: As a conclusion, it can be said that the seizure activity triggered by KA has the potential to change the gene expression levels of the enzymes responsible for drug metabolism in the hippocampus of rats.
- 28 November 2023
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 53 (3) , 287-293
The investigation of drug repurposing for HDAC1 inhibitory effects by in silico and in vitro methods
- 28 November 2023
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 53 (3) , 287-293
The investigation of drug repurposing for HDAC1 inhibitory effects by in silico and in vitro methods
- 31 August 2022
- Published by Erzincan Universitesi Fen Bilimleri Ensitusu Dergisi in Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 15 (2) , 609-621
The Effects of Prenatal Stress on Cortical and Hippocampal Gene Expression Profiles of DNA Methyltransferases and Histone Deacetylases in Female Rats
The aim of this study was to investigate the effects of prenatal stress (PS) on mRNA levels of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) in cerebral cortex and hippocampus of female rats. PS was induced in rats with dexamethasone (Dex). From gestation day 14 to 21, pregnant rats were injected daily with Dex (100 μg/kg) or saline. After birth, at 3 months of age, female rats were decapitated (n=5). The effects of Dex on epigenetic mechanisms were investigated by real-time PCR through mRNA levels of DNMT1, DNMT3a, DNMT3b, HDAC1 and HDAC2. Statistical significant differences were determined with one-way analysis of variance. Prenatal Dex exposure caused significant increases in DNMT3a, HDAC1 and HDAC2 mRNA levels in cortex and hippocampus. We further found that DNMT3b mRNA levels significantly increased in hippocampus but decreased in cortex of Dex group. No significant differences were found in DNMT1 mRNA levels. It was concluded that PS may trigger dysregulation of epigenetic mechanisms in cortex and hippocampus of female rats through alterations in gene expression profiles of DNMT3a, DNMT3b, HDAC1 and HDAC2.
- 31 August 2022
- Published by Erzincan Universitesi Fen Bilimleri Ensitusu Dergisi in Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 15 (2) , 609-621
The Effects of Prenatal Stress on Cortical and Hippocampal Gene Expression Profiles of DNA Methyltransferases and Histone Deacetylases in Female Rats
The aim of this study was to investigate the effects of prenatal stress (PS) on mRNA levels of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) in cerebral cortex and hippocampus of female rats. PS was induced in rats with dexamethasone (Dex). From gestation day 14 to 21, pregnant rats were injected daily with Dex (100 μg/kg) or saline. After birth, at 3 months of age, female rats were decapitated (n=5). The effects of Dex on epigenetic mechanisms were investigated by real-time PCR through mRNA levels of DNMT1, DNMT3a, DNMT3b, HDAC1 and HDAC2. Statistical significant differences were determined with one-way analysis of variance. Prenatal Dex exposure caused significant increases in DNMT3a, HDAC1 and HDAC2 mRNA levels in cortex and hippocampus. We further found that DNMT3b mRNA levels significantly increased in hippocampus but decreased in cortex of Dex group. No significant differences were found in DNMT1 mRNA levels. It was concluded that PS may trigger dysregulation of epigenetic mechanisms in cortex and hippocampus of female rats through alterations in gene expression profiles of DNMT3a, DNMT3b, HDAC1 and HDAC2.
- 1 August 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (8) , 2372-2380
Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)–Induced Toxicity
- 1 August 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (8) , 2372-2380
Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)–Induced Toxicity
- 8 August 2014
- Published by Wiley in Cell Biochemistry and Function
- Vol. 32 (7) , 557-564
Ex vivo protective effects of nicotinamide and 3‐aminobenzamide on rat synaptosomes treated with Aβ(1–42)
Alzheimer's disease (AD) is the most common form of dementia and is characterized by the presence of senile plaques and neurofibrillary tangles, along with synaptic loss. The underlying mechanisms of AD are not clarified yet, but oxidative stress and mitochondrial dysfunction are important factors. Overactivation of poly(adenosine diphosphate ribose) polymerase‐1 (PARP‐1) enzyme has been known to cause neuroinflammation and cell death in neurodegenerative processes. The aim of the present study was to investigate the protective effects of the PARP‐1 inhibitors, 3‐aminobenzamide (3‐AB) and nicotinamide (NA), against amyloid β peptide (1–42) (Aβ(1–42))‐induced oxidative damage and mitochondrial reduction capacity on isolated synaptosomes. Rats were injected intraperitoneally with 3‐AB (30–100 mg kg−1), NA (100–500 mg kg−1) or with saline for 7 days. Synaptosomes were incubated with 10–30 μM Aβ(1–42) or saline for 6 h at 37 °C. Ex vivo Aβ(1–42) treatment significantly induced oxidative stress and mitochondrial dysfunction in synaptosomes of the saline group, while synaptosomes of 3‐AB and NA groups showed significant decreases in lipid peroxidation, reactive oxygen species production and protein oxidation. Moreover, both NA and 3‐AB were able to improve the mitochondrial reduction capacity against Aβ(1–42). These data suggest that NA and 3‐AB may have protective effects in neurodegenerative processes because of the reduced levels of oxidative stress and the improvement of mitochondrial function. Copyright © 2014 John Wiley & Sons, Ltd.
- 8 August 2014
- Published by Wiley in Cell Biochemistry and Function
- Vol. 32 (7) , 557-564
Ex vivo protective effects of nicotinamide and 3‐aminobenzamide on rat synaptosomes treated with Aβ(1–42)
Alzheimer's disease (AD) is the most common form of dementia and is characterized by the presence of senile plaques and neurofibrillary tangles, along with synaptic loss. The underlying mechanisms of AD are not clarified yet, but oxidative stress and mitochondrial dysfunction are important factors. Overactivation of poly(adenosine diphosphate ribose) polymerase‐1 (PARP‐1) enzyme has been known to cause neuroinflammation and cell death in neurodegenerative processes. The aim of the present study was to investigate the protective effects of the PARP‐1 inhibitors, 3‐aminobenzamide (3‐AB) and nicotinamide (NA), against amyloid β peptide (1–42) (Aβ(1–42))‐induced oxidative damage and mitochondrial reduction capacity on isolated synaptosomes. Rats were injected intraperitoneally with 3‐AB (30–100 mg kg−1), NA (100–500 mg kg−1) or with saline for 7 days. Synaptosomes were incubated with 10–30 μM Aβ(1–42) or saline for 6 h at 37 °C. Ex vivo Aβ(1–42) treatment significantly induced oxidative stress and mitochondrial dysfunction in synaptosomes of the saline group, while synaptosomes of 3‐AB and NA groups showed significant decreases in lipid peroxidation, reactive oxygen species production and protein oxidation. Moreover, both NA and 3‐AB were able to improve the mitochondrial reduction capacity against Aβ(1–42). These data suggest that NA and 3‐AB may have protective effects in neurodegenerative processes because of the reduced levels of oxidative stress and the improvement of mitochondrial function. Copyright © 2014 John Wiley & Sons, Ltd.
- 11 October 2013
- Published by Taylor & Francis in Free Radical Research
- Vol. 48 (2) , 146-158
Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer's disease
The underlying mechanisms of Alzheimer's Disease (AD) are still unclear. It is suggested that poly(ADP-ribose) polymerase-1 (PARP-1) overactivation can cause neuroinflammation and cell death. In this study we searched the effects of nicotinamide (NA), endogenous PARP-1 inhibitor, on oxidative stress, apoptosis, and the regulation of PARP-1 and nuclear factor kappa B (NF-κB) in amyloid beta peptide (1-42) (Aβ(1-42))-induced neurodegeneration. Sprague-Dawley rats were divided into four groups as control, Aβ(1-42), Aβ(1-42) + NA(100 and 500 mg/kg). All groups were stereotaxically injected bilaterally into the hippocampus with Aβ(1-42) or saline. After surgery NA administrations were made intraperitoneally (ip) for 7 days. In order to investigate the effects of Aβ(1-42) and NA, protein carbonyls, lipid peroxidation, reactive oxygen species (ROS) production, glutathione (GSH) levels, activities of antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase), mitochondrial function, mRNA and protein levels of PARP-1, NF-κB, p53, Bax, and Bcl-2 were measured in specific brain regions such as cortex and hippocampus. Aβ(1-42) treatment only increased the oxidative stress parameters and caused decline in antioxidant enzyme activities, mitochondrial function, and GSH levels. Also, overexpression of PARP-1, NF-κB, p53, Bax, and the decreased levels of Bcl-2 were observed in Aβ(1-42)-treated group. NA treatments against Aβ(1-42)-upregulated Bcl-2 and downregulated PARP-1, NF-κB, p53, and Bax levels. NA treatments also decreased the oxidative stress parameters and elevated antioxidant enzyme activities, GSH levels, and mitochondrial function against Aβ(1-42) treatment. These data suggest that NA may have a therapeutic potential in neurodegenerative processes due to the decreased levels of oxidative stress, apoptosis, and PARP-1 activity.
- 11 October 2013
- Published by Taylor & Francis in Free Radical Research
- Vol. 48 (2) , 146-158
Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer's disease
The underlying mechanisms of Alzheimer's Disease (AD) are still unclear. It is suggested that poly(ADP-ribose) polymerase-1 (PARP-1) overactivation can cause neuroinflammation and cell death. In this study we searched the effects of nicotinamide (NA), endogenous PARP-1 inhibitor, on oxidative stress, apoptosis, and the regulation of PARP-1 and nuclear factor kappa B (NF-κB) in amyloid beta peptide (1-42) (Aβ(1-42))-induced neurodegeneration. Sprague-Dawley rats were divided into four groups as control, Aβ(1-42), Aβ(1-42) + NA(100 and 500 mg/kg). All groups were stereotaxically injected bilaterally into the hippocampus with Aβ(1-42) or saline. After surgery NA administrations were made intraperitoneally (ip) for 7 days. In order to investigate the effects of Aβ(1-42) and NA, protein carbonyls, lipid peroxidation, reactive oxygen species (ROS) production, glutathione (GSH) levels, activities of antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase), mitochondrial function, mRNA and protein levels of PARP-1, NF-κB, p53, Bax, and Bcl-2 were measured in specific brain regions such as cortex and hippocampus. Aβ(1-42) treatment only increased the oxidative stress parameters and caused decline in antioxidant enzyme activities, mitochondrial function, and GSH levels. Also, overexpression of PARP-1, NF-κB, p53, Bax, and the decreased levels of Bcl-2 were observed in Aβ(1-42)-treated group. NA treatments against Aβ(1-42)-upregulated Bcl-2 and downregulated PARP-1, NF-κB, p53, and Bax levels. NA treatments also decreased the oxidative stress parameters and elevated antioxidant enzyme activities, GSH levels, and mitochondrial function against Aβ(1-42) treatment. These data suggest that NA may have a therapeutic potential in neurodegenerative processes due to the decreased levels of oxidative stress, apoptosis, and PARP-1 activity.